🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Goldman Sachs neutral on EPAM Systems stock

EditorAhmed Abdulazez Abdulkadir
Published 06/24/2024, 05:27 AM
EPAM
-

On Monday, Goldman Sachs initiated coverage on EPAM Systems (NYSE: EPAM) with a Neutral rating and set a price target of $200. The firm provided insights into the company's current position and future prospects, noting EPAM's specialization in digital application engineering and integration services. Goldman Sachs recognized EPAM as a differentiated provider within the high-end engineering services sector, particularly in applications and data integration.

The company's core business is seen as intact despite the disruptions caused by the conflict in Ukraine, which has affected its delivery capabilities. The firm anticipates that EPAM Systems will eventually resume double-digit growth as demand for new technology builds. However, the current outlook suggests that business trends may remain subdued in the near term. This is attributed to the nominal pressures arising from ongoing changes to EPAM's delivery model and the company's increased focus on India-based delivery.

Goldman Sachs' assessment reflects an expectation that EPAM Systems will navigate through the current challenges and position itself for growth in the future. The company's ability to adapt to the changing landscape and maintain its specialized service offerings is crucial for its long-term success.

The $200 price target set by Goldman Sachs indicates the firm's valuation of EPAM's stock based on the company's current situation and the expected trajectory of its performance. As the market processes this new information, investors will be watching EPAM Systems' progress closely, particularly how it manages the shifts in its delivery footprint and captures demand for its services.

In other recent news, EPAM Systems has acquired Odysseus Data Services, a move aimed at enhancing its capacity in the life sciences sector by integrating advanced data analytics and artificial intelligence. This merger is expected to drive innovation and improve outcomes in the life sciences domain. In the wake of these developments, Piper Sandler maintained an Overweight rating on EPAM's stock despite a revised price target of $230.

On the other hand, Wolfe Research downgraded EPAM Systems from Outperform to Peer Perform due to macroeconomic challenges and operational shifts towards India. Redburn-Atlantic initiated coverage on EPAM Systems with a Neutral rating, citing significant operational changes due to the ongoing conflict in Ukraine, which has impacted the company's revenues. Furthermore, EPAM Systems has faced a series of price target cuts from Mizuho, Needham, and Jefferies, following a reduction in its revenue forecast for the year.

InvestingPro Insights

Following Goldman Sachs' neutral stance on EPAM Systems, a closer look at the company's financial health and market performance through InvestingPro's lens provides additional context for investors. EPAM Systems boasts a robust balance sheet, as evidenced by holding more cash than debt, which is a reassuring sign of financial stability. Moreover, the company's liquid assets surpass its short-term obligations, indicating a strong position to meet immediate financial needs.

While the stock has experienced a decline in the past several months, with a 31.77% drop over the last three months and a 37.72% fall in the past six months, analysts remain optimistic about EPAM's profitability, predicting the company will be profitable this year and noting that it has been profitable over the last twelve months. This resilience, coupled with a high return over the last decade, suggests potential for recovery and growth despite recent market volatility.

InvestingPro data highlights a market capitalization of $10.71 billion and a price-to-earnings (P/E) ratio of 24.62, which adjusts to 21.3 when considering the last twelve months as of Q1 2024. The price-to-book ratio stands at 3.08 for the same period. Despite a slight revenue contraction of 4.5% in the last twelve months as of Q1 2024, EPAM's gross profit margin remains healthy at 30.6%, indicating effective cost management and a solid core business model.

To delve deeper into EPAM's potential and uncover more insights, investors can explore additional InvestingPro Tips at https://www.investing.com/pro/EPAM. There are 9 more tips available, which can provide further guidance for investment decisions. For those interested in a comprehensive analysis, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.